# 人相診断AI vs 命日ノート i

The clearest difference is in-app purchases: 命日ノート i at none against 人相診断AI's 3. 命日ノート i also leads on ads (none vs shown) and update cadence (every 3 days vs weekly). On price there is nothing between them.

Both are free to download. 人相診断AI sells 3 in-app purchases, starting at $2.99 per month. 命日ノート i asks for nothing beyond the download.

人相診断AI ships an update weekly, 命日ノート i every 3 days. The most recent releases landed on October 25, 2026 and October 7, 2026 respectively.

## The numbers

| Metric | 人相診断AI | 命日ノート i |
| --- | --- | --- |
| Price | Free | Free |
| In-app purchases | Yes | **No** |
| Ads | Yes | **No** |
| Update frequency | Weekly | **Every 3 days** |
| Size | 25 MB | 52 MB |
| Requires iOS | 17.0 | **15.0** |
| Devices | iPhone | **iPhone, iPad, iPod** |
| Age rating | 4+ | 4+ |
| Developer | [kazunari aoki](https://appshunter.io/developer/6774180811) | [ZEN APP](https://appshunter.io/developer/1237409734) |

## What reviewers say

### 人相診断AI

[App page](https://appshunter.io/ios/app/ai-16/id6775012372)

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases (3)**

| Purchase | Price | Billing |
| --- | --- | --- |
| Pro 月額 | $2.99 | per month |
| Pro 年額 | $22.99 | per year |
| Pro（買い切り） | $2.99 | one-time |


### 命日ノート i

[App page](https://appshunter.io/ios/app/i/id6810020979)

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


## Frequently asked questions

### Is 人相診断AI free?

人相診断AI is free to download, with in-app purchases available.

### Is 命日ノート i free?

命日ノート i is free to download, with no in-app purchases.

### Do 人相診断AI or 命日ノート i have ads?

人相診断AI shows ads; 命日ノート i does not.

### Which is updated more often, 人相診断AI or 命日ノート i?

人相診断AI ships an update weekly, and 命日ノート i every 3 days. Most recently, 人相診断AI was updated on October 25, 2026 and 命日ノート i on October 7, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*